Survival and Outcomes after Noncompletion of Treatment for Anal Cancer

Ankit Jain; Desmond Yip; Amy Shorthouse

doi:10.1001/jamaoncol.2020.3952

Survival and Outcomes after Noncompletion of Treatment for Anal Cancer

Ankit Jain^*, Desmond Yip, Amy Shorthouse

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

Abstract

We read with great interest the Original Investigation from Raphael et al1 on factors associated with chemoradiation interruptions and noncompletion among patients with squamous cell anal carcinoma. In this Canadian population-based, retrospective cohort study, 1125 patients with stage I to III anal cancer were treated with curative-intent radiotherapy. This number is larger than any of the published randomized clinical trials with chemoradiation in squamous cell anal carcinoma.

Original language	English
Pages (from-to)	1977
Number of pages	1
Journal	JAMA Oncology
Volume	6
Issue number	12
DOIs	https://doi.org/10.1001/jamaoncol.2020.3952
Publication status	Published - Dec 2020

Access to Document

10.1001/jamaoncol.2020.3952

Cite this

@article{96692573cf284df7a6dabc34335da305,

title = "Survival and Outcomes after Noncompletion of Treatment for Anal Cancer",

abstract = "We read with great interest the Original Investigation from Raphael et al1 on factors associated with chemoradiation interruptions and noncompletion among patients with squamous cell anal carcinoma. In this Canadian population-based, retrospective cohort study, 1125 patients with stage I to III anal cancer were treated with curative-intent radiotherapy. This number is larger than any of the published randomized clinical trials with chemoradiation in squamous cell anal carcinoma.",

author = "Ankit Jain and Desmond Yip and Amy Shorthouse",

year = "2020",

month = dec,

doi = "10.1001/jamaoncol.2020.3952",

language = "English",

volume = "6",

pages = "1977",

journal = "JAMA Oncology",

issn = "2374-2437",

publisher = "American Medical Association",

number = "12",

}

TY - JOUR

T1 - Survival and Outcomes after Noncompletion of Treatment for Anal Cancer

AU - Jain, Ankit

AU - Yip, Desmond

AU - Shorthouse, Amy

PY - 2020/12

Y1 - 2020/12

N2 - We read with great interest the Original Investigation from Raphael et al1 on factors associated with chemoradiation interruptions and noncompletion among patients with squamous cell anal carcinoma. In this Canadian population-based, retrospective cohort study, 1125 patients with stage I to III anal cancer were treated with curative-intent radiotherapy. This number is larger than any of the published randomized clinical trials with chemoradiation in squamous cell anal carcinoma.

AB - We read with great interest the Original Investigation from Raphael et al1 on factors associated with chemoradiation interruptions and noncompletion among patients with squamous cell anal carcinoma. In this Canadian population-based, retrospective cohort study, 1125 patients with stage I to III anal cancer were treated with curative-intent radiotherapy. This number is larger than any of the published randomized clinical trials with chemoradiation in squamous cell anal carcinoma.

UR - http://www.scopus.com/inward/record.url?scp=85092624171&partnerID=8YFLogxK

U2 - 10.1001/jamaoncol.2020.3952

DO - 10.1001/jamaoncol.2020.3952

M3 - Letter

SN - 2374-2437

VL - 6

SP - 1977

JO - JAMA Oncology

JF - JAMA Oncology

IS - 12

ER -

Survival and Outcomes after Noncompletion of Treatment for Anal Cancer

Abstract

Access to Document

Other files and links

Fingerprint

Cite this